Table 1.
Drug | MIC (μg/ml) for each isolate (date of isolation, specimen type)a |
||||||
---|---|---|---|---|---|---|---|
EC-1 (14/9/2007, urine) | EC-2 (28/7/2009, bile) | EC-3 (30/7/2009, abdomen) | EC-8 (11/8/2009, abdomen) | EC-9 (12/11/2009, abdomen) | EC-11 (30/7/2009, urine) | EC-13 (23/10/2009, abdomen) | |
Cefotaxime | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 4 | 4 |
Ceftazidime | 16 | 32 | 32 | ≥256 | ≥256 | 32 | 32 |
Ceftriaxone | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 2 | 2 |
Cefepime | 2 | ≥16 | ≥16 | ≥16 | ≥16 | 0.5 | 0.5 |
Imipenem | 0.125 | 0.125 | 0.125 | ≥32 | ≥32 | 0.125 | 0.125 |
Meropenem | 0.012 | 0.125 | 0.125 | ≥32 | ≥32 | 0.012 | 0.012 |
The susceptibility (MIC in μg/ml) of the isolates was determined by Etest. The dates of isolation are formatted as day/month/year.